XPH

Fund Description
The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible before expenses the total return performance of the S&P Pharmaceuticals Select Industry Index (ticker: SPSIPHTR).
Fund Profile
Fund Name SPDR S&P Pharmaceuticals ETF
Fund Exchange Ticker XPH
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A7220
Net Expense Ratio 0.35 %
Fund Inception Date 19 June 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name S&P Pharmaceuticals Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 21 August 2019
Asset Under Management 192.10 Million (USD)
1 Month Total Return -2.90 %
Year To Date Return 0.18 %
1 Year Total Return -25.31 %
3 Year Annualized Total Return -7.36 %
NAV 36.589
Share Outstanding 5,250,270
Top 10 Holdings (20 August 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
ALLERGAN PLC AGN EQUI 0.0632140900
HORIZON THERAPEUTICS PLC HZNP EQUI 0.0539845400
Zoetis Inc. Class A ZTS EQUI 0.0524002800
MYLAN NV MYL EQUI 0.0516569300
PERRIGO CO PLC PRGO EQUI 0.0502687500
JAZZ PHARMACEUTICALS PLC JAZZ EQUI 0.0481813900
MERCK & CO. INC. MRK EQUI 0.0476522300
BRISTOL-MYERS SQUIBB CO BMY EQUI 0.0461230100
ELI LILLY & CO LLY EQUI 0.0457542400
JOHNSON & JOHNSON JNJ EQUI 0.0429367200